₹266.85*
MRP ₹296.5
10% off
₹252.02*
MRP ₹296.5
15% CB
₹44.48 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition :
CLARITHROMYCIN-125MG
Manufacturer/Marketer :
Ind Swift Laboratories Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Clarie DT 125 Tablet:
Co-administration of Clarie DT 125 Tablet and Simvastatin can increase the blood levels and effects of Simvastatin. This can increase the risk of side effects such as liver damage and rhabdomyolysis(which involves the breakdown of skeletal muscle tissue).
How to manage the interaction:
Taking Clarie DT 125 Tablet and Simvastatin together is not recommended as it can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like muscle pain, tenderness, or weakness, fever or dark colored urine, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Co-administration of Clarie DT 125 Tablet and Simvastatin can increase the blood levels and effects of Simvastatin. This can increase the risk of side effects such as liver damage and rhabdomyolysis(which involves the breakdown of skeletal muscle tissue).
How to manage the interaction:
Taking Clarie DT 125 Tablet and Simvastatin together is not recommended as it can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like muscle pain, tenderness, or weakness, fever or dark colored urine, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Isavuconazole is taken with Clarie DT 125 Tablet, it can increase the risk of side effects.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Isavuconazole can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like nausea, vomiting, or diarrhoea, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
When Isavuconazole is taken with Clarie DT 125 Tablet, it can increase the risk of side effects.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Isavuconazole can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like nausea, vomiting, or diarrhoea, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
ClarithromycinDroperidol
Critical
How does the drug interact with Clarie DT 125 Tablet:
Co-administration of Droperidol with Clarie DT 125 Tablet can increase the risk of an irregular heart rhythm.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Droperidol can result in an interaction, it should be taken only if a doctor has advised it. However, if you experience dizziness, lightheadedness, fainting, shortness of breath, or heart palpitation, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Droperidol with Clarie DT 125 Tablet can increase the risk of an irregular heart rhythm.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Droperidol can result in an interaction, it should be taken only if a doctor has advised it. However, if you experience dizziness, lightheadedness, fainting, shortness of breath, or heart palpitation, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
ClarithromycinTerfenadine
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Terfenadine is taken with Clarie DT 125 Tablet, the amount of Terfenadine in the blood can go up.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Terfenadine can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
When Terfenadine is taken with Clarie DT 125 Tablet, the amount of Terfenadine in the blood can go up.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Terfenadine can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Critical
How does the drug interact with Clarie DT 125 Tablet:
Coadministration of colchicine with Clarie DT 125 Tablet may increase the blood levels of colchicine, increasing the risk of serious side effects.
How to manage the interaction:
Taking Colchicine with Clarie DT 125 Tablet is not recommended, they can be taken together if advised by your doctor. However, contact your doctor if you experience abdominal pain, nausea, vomiting, diarrhea, fever, muscle pain, weakness, fatigue, and/or numbness or tingling in your hands and feet. Do not stop taking any medications without consulting a doctor.
Coadministration of colchicine with Clarie DT 125 Tablet may increase the blood levels of colchicine, increasing the risk of serious side effects.
How to manage the interaction:
Taking Colchicine with Clarie DT 125 Tablet is not recommended, they can be taken together if advised by your doctor. However, contact your doctor if you experience abdominal pain, nausea, vomiting, diarrhea, fever, muscle pain, weakness, fatigue, and/or numbness or tingling in your hands and feet. Do not stop taking any medications without consulting a doctor.
ClarithromycinLomitapide
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Lomitapide is taken with Clarie DT 125 Tablet, it can lower the metabolism of Lomitapide.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Lomitapide can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like diarrhea, nausea, vomiting, stomach pain or discomfort, indigestion, gas, constipation, and liver damage, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
When Lomitapide is taken with Clarie DT 125 Tablet, it can lower the metabolism of Lomitapide.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Lomitapide can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like diarrhea, nausea, vomiting, stomach pain or discomfort, indigestion, gas, constipation, and liver damage, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Nimodipine is taken with Clarie DT 125 Tablet, it can increase the risk of side effects.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Nimodipine is not recommended as it can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like irregular heart rhythm, swelling, and low blood pressure, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
When Nimodipine is taken with Clarie DT 125 Tablet, it can increase the risk of side effects.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Nimodipine is not recommended as it can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like irregular heart rhythm, swelling, and low blood pressure, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
ClarithromycinConivaptan
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Clarie DT 125 Tablet is taken with Conivaptan, it can lower the rate at which Conivaptan is broken down in the body.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Convivaptan can result in an interaction, it should be taken only if a doctor has advised it. However, if you experience swallowing, trouble speaking, muscle weakness, trouble controlling body movements, confusion, mood changes, or seizures, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
When Clarie DT 125 Tablet is taken with Conivaptan, it can lower the rate at which Conivaptan is broken down in the body.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Convivaptan can result in an interaction, it should be taken only if a doctor has advised it. However, if you experience swallowing, trouble speaking, muscle weakness, trouble controlling body movements, confusion, mood changes, or seizures, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
ClarithromycinSaquinavir
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Clarie DT 125 Tablet is taken with Saquinavir, increases the risk of an irregular heart rhythm.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Saquinavir can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
When Clarie DT 125 Tablet is taken with Saquinavir, increases the risk of an irregular heart rhythm.
How to manage the interaction:
Co-administration of Clarie DT 125 Tablet and Saquinavir can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
ClarithromycinAstemizole
Critical
How does the drug interact with Clarie DT 125 Tablet:
When Astemizole is taken with Clarie DT 125 Tablet, it can cause a decrease in the metabolism of Astemizole.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Astemizole is not recommended, please consult your doctor before taking it.
When Astemizole is taken with Clarie DT 125 Tablet, it can cause a decrease in the metabolism of Astemizole.
How to manage the interaction:
Taking Clarie DT 125 Tablet with Astemizole is not recommended, please consult your doctor before taking it.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
Author Details
Drug-Diseases Interactions
CLARITHROMYCIN-125MGOther bacterial intestinal infections
Severe
CLARITHROMYCIN-125MGToxic liver disease
Moderate
Drug-Diseases Interactions
Login/Sign Up
CLARITHROMYCIN-125MGOther bacterial intestinal infections
Severe
How does the disease interact with Clarie DT 125 Tablet:
Almost all antibacterial medications have been associated with cases of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis. Clindamycin and lincomycin are two of the most frequent those involved.
How to manage the interaction:
Anti-bacterial medicines may cause Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis. Therapy should be administered with caution in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with cases of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis. Clindamycin and lincomycin are two of the most frequent those involved.
How to manage the interaction:
Anti-bacterial medicines may cause Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis. Therapy should be administered with caution in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C difficile is advised.
CLARITHROMYCIN-125MGToxic liver disease
Moderate
How does the disease interact with Clarie DT 125 Tablet:
Patients on Clarie DT 125 Tablet have been reported to experience hepatic dysfunction, including elevated liver enzymes, cholestatic and/or hepatocellular hepatitis, with or without jaundice. Using this medication to patients with hepatic impairment requires caution and close monitoring. If hepatitis signs and symptoms appear, treatment must be stopped.
How to manage the interaction:
Caution and monitoring is advised if Clarie DT 125 Tablet is used in patients with liver impairment. Treatment must be discontinued immediately if signs and symptoms of hepatitis such as anorexia, jaundice, dark urine, pruritus, or tender abdomen occur. The use of Clarie DT 125 Tablet is contraindicated in patients with a history of cholestatic jaundice or liver impairment associated with the prior use of Clarie DT 125 Tablet.
Patients on Clarie DT 125 Tablet have been reported to experience hepatic dysfunction, including elevated liver enzymes, cholestatic and/or hepatocellular hepatitis, with or without jaundice. Using this medication to patients with hepatic impairment requires caution and close monitoring. If hepatitis signs and symptoms appear, treatment must be stopped.
How to manage the interaction:
Caution and monitoring is advised if Clarie DT 125 Tablet is used in patients with liver impairment. Treatment must be discontinued immediately if signs and symptoms of hepatitis such as anorexia, jaundice, dark urine, pruritus, or tender abdomen occur. The use of Clarie DT 125 Tablet is contraindicated in patients with a history of cholestatic jaundice or liver impairment associated with the prior use of Clarie DT 125 Tablet.
CLARITHROMYCIN-125MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clarie DT 125 Tablet:
The kidney and liver are the organs that eliminate of Clarie DT 125 Tablet the most. In individuals with severe renal impairment (CrCl 30 mL/min), a lower dose or longer dosing intervals are advised. Patients with mild to moderate renal impairment often do not require dosage modifications, while medication accumulation may happen if there is concurrent liver illness. It is suggested to monitor.
How to manage the interaction:
Dose adjustment may be needed in patients with severe kidney impairment. Monitoring is advised in patients with mild to moderate kidney impairment.
The kidney and liver are the organs that eliminate of Clarie DT 125 Tablet the most. In individuals with severe renal impairment (CrCl 30 mL/min), a lower dose or longer dosing intervals are advised. Patients with mild to moderate renal impairment often do not require dosage modifications, while medication accumulation may happen if there is concurrent liver illness. It is suggested to monitor.
How to manage the interaction:
Dose adjustment may be needed in patients with severe kidney impairment. Monitoring is advised in patients with mild to moderate kidney impairment.
CLARITHROMYCIN-125MGMyasthenia gravis and other myoneural disorders
Moderate
How does the disease interact with Clarie DT 125 Tablet:
Myasthenia gravis symptoms have been observed to worsen and new myasthenic syndrome symptoms appear when macrolide antibiotics are used, according to reports. In patients who have a history of myasthenia gravis, therapy with these medicines should be used with caution.
How to manage the interaction:
Therapy should be administered cautiously in patients with a history of myasthenia gravis as the use of macrolide antibiotics has been reported to exacerbate symptoms of myasthenia gravis.
Myasthenia gravis symptoms have been observed to worsen and new myasthenic syndrome symptoms appear when macrolide antibiotics are used, according to reports. In patients who have a history of myasthenia gravis, therapy with these medicines should be used with caution.
How to manage the interaction:
Therapy should be administered cautiously in patients with a history of myasthenia gravis as the use of macrolide antibiotics has been reported to exacerbate symptoms of myasthenia gravis.
CLARITHROMYCIN-125MGAbnormal results of function studies
Moderate
How does the disease interact with Clarie DT 125 Tablet:
Macrolides have been associated with an increase in the QT interval and occasional cases of arrhythmia. Patients with known QT interval prolongation, ventricular cardiac arrhythmia, including torsades de pointes, patients with proarrhythmic conditions like untreated hypokalemia or hypomagnesemia, clinically significant bradycardia, or patients taking other drugs that prolong the QT interval should avoid taking Clarie DT 125 Tablet and erythromycin.
How to manage the interaction:
Clarie DT 125 Tablet should be avoided in patients with known prolongation of the QT interval, abnormal heart rhythm, uncorrected low potassium or low magnesium, clinically significant slow heart rate, or receiving other drugs that prolong the QT interval.
Macrolides have been associated with an increase in the QT interval and occasional cases of arrhythmia. Patients with known QT interval prolongation, ventricular cardiac arrhythmia, including torsades de pointes, patients with proarrhythmic conditions like untreated hypokalemia or hypomagnesemia, clinically significant bradycardia, or patients taking other drugs that prolong the QT interval should avoid taking Clarie DT 125 Tablet and erythromycin.
How to manage the interaction:
Clarie DT 125 Tablet should be avoided in patients with known prolongation of the QT interval, abnormal heart rhythm, uncorrected low potassium or low magnesium, clinically significant slow heart rate, or receiving other drugs that prolong the QT interval.
Have a query?
